ImmunityBio (IBRX) Jumps 18% on Anktiva Access Expansion
We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at where ImmunityBio, Inc.
Posts Tagged ‘NASDAQ:IBRX’
Why ImmunityBio, Inc. (IBRX) Skyrocketed Today
We recently published a list of These 10 Stocks Are On Fire Right Now. In this article, we are going to take a look at where ImmunityBio, Inc.
Why ImmunityBio, Inc. (IBRX) Surged On Thursday
We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild.
Piper Sandler Upgrades ImmunityBio (IBRX) to Overweight, Lifts PT
In a research note, the analyst told investors that the rating is based on the development of the company's ANKTIVA, t-haNK & M-ceNK cell therapies, and DNA vaccines, which combat...
Why ImmunityBio, Inc. (IBRX) Crashed Today
We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where ImmunityBio, Inc.
Jim Cramer Notes ImmunityBio (IBRX) Has “Been Losing Money Forever”
We recently published a list of Jim Cramer’s Recent Thoughts on These 15 Stocks.
Jim Cramer’s Recent Thoughts on These 15 Stocks
“Stories like the US debt downgrade story from Friday, they are classic… Stories that scare people out of very fine stocks that could otherwise make them rich.
10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities...
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
12 Stocks Under $10 With High Upside Potential
Small-cap stocks in the U.S. have suffered as the broader market is under pressure due to the ongoing tariff policy transition.
Why ImmunityBio (IBRX) Is Surging Today
ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an "alternative source of BCG." Specifically, the company will now be able...
12 Stocks That Will Double in 2025
A lot is happening in the market, especially within the growth sectors.
12 Stocks Under $5 With Biggest Upside Potential
On January 20, Bloomberg reported that relief swept through the markets as it became clear that Donald Trump would not immediately impose China-specific tariffs on his first day...
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential
On December 30, MJP Wealth Advisors chief investment officer Brian Vendig appeared on Yahoo! Finance's Catalysts to discuss the potential outlook of small cap stocks in 2025.
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
10 Best Fast-Growing Penny Stocks to Buy Now
September tends to be the worst month for the stock market, however 2024 might just be an outlier in history.
12 Most Shorted Stocks in 2024
Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating...
12 Best Day Trading Stocks To Buy
Over the past few years, the rise of a new generation of stock traders that like to engage in risky bets, coupled with the advent of stock trading mobile applications, has given...
15 Best Drug Stocks to Buy Now
According to the International Federation of Pharmaceuticals Manufacturers & Associations, the global pharmaceutical sector or the drug industry is expected to post annual revenues...
10 Best Immunotherapy Stocks To Buy Now
In this article, we discuss 10 best immunotherapy stocks to buy now.
Hedge Fund and Insider Trading News: Mike Novogratz, Chris Hohn, George Soros, Brevan Howard Asset Management, Alkeon Capital, Bluebell Capital Partners, Facedrive Inc (FDVRF), Sprout Social Inc (SPT), and More
Soros Fund Management, the family office of billionaire investor and philanthropist George Soros, has recently been confirmed as owning bitcoin by its CEO/CIO Dawn Fitzpatrick...
Do Hedge Funds Love ImmunityBio, Inc. (IBRX)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
